STOBOCLO

DENOSUMAB-BMWO · CELLTRION USA, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for STOBOCLO, covering 2025-02-28 to 2026-01-14. Get the full timeline:

Most recent: EMA Authorised: Stoboclo (denosumab) — Celltrion Healthcare Hungary Kft.